ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p972.xmlWealth, Health Expenditure, and Cancer: A National Perspective2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p972.pdf2026-04-18Wealth, Health Expenditure, and Cancer: A National Perspectivehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p979.xmlPredictors of In-Hospital Mortality in Patients With Metastatic Cancer Receiving Specific Critical Care Therapies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p979.pdf2026-04-18Predictors of In-Hospital Mortality in Patients With Metastatic Cancer Receiving Specific Critical Care Therapieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p961.xmlNCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p961.pdf2026-04-18NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p945.xmlNCCN Guidelines Insights: Melanoma, Version 3.20162026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p945.pdf2026-04-18NCCN Guidelines Insights: Melanoma, Version 3.2016https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p939.xmlDonor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p939.pdf2026-04-18Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p935.xmlImmunotherapy for Lung Cancer: Many Questions Yet to Be Answered2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p935.pdf2026-04-18Immunotherapy for Lung Cancer: Many Questions Yet to Be Answeredhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p959.xmlNCCN's Commitment to Medication Safety: The Vincristine Initiative2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p959.pdf2026-04-18NCCN's Commitment to Medication Safety: The Vincristine Initiativehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-pxxvi.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-pxxvi.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p929.xmlI'll Have Another Shot, Please!2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p929.pdf2026-04-18I'll Have Another Shot, Please!https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-pxxxiv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-pxxxiv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1001.xmlAssociations Between End-of-Life Cancer Care Patterns and Medicare Expenditures2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1001.pdf2026-04-18Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditureshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p993.xmlIs Advanced Imaging in Early-Stage Breast Cancer Ever Warranted? Reconciling Clinical Judgment With Common Quality Measures2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p993.pdf2026-04-18Is Advanced Imaging in Early-Stage Breast Cancer Ever Warranted? Reconciling Clinical Judgment With Common Quality Measureshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1033.xmlBiomarkers in Colorectal Cancer Screening2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1033.pdf2026-04-18Biomarkers in Colorectal Cancer Screeninghttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1043.xmlCounterpoint: Wealth, Health Expenditure, and Cancer—Translating Research Into Efficient Policies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1043.pdf2026-04-18Counterpoint: Wealth, Health Expenditure, and Cancer—Translating Research Into Efficient Policieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1041.xmlPoint: The Power of Data to (Mis)Guide Policy to Improve Cancer Health Equity2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1041.pdf2026-04-18Point: The Power of Data to (Mis)Guide Policy to Improve Cancer Health Equityhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1010.xmlGenetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/8/article-p1010.pdf2026-04-18Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology